Year-over-year earnings per share growth for the last twelve months: dbv-technologies.com (DBVT)

Official company branding of DBV Technologies S.A. (DBVT)

Quarterly EPS fluctuations on the GURU.Markets platform demonstrate how DBV Technologies S.A. (DBVT) is advancing dermatology through partnerships with clinics to implement Viaskin patches. The success of the French biotech system currently depends on FDA and EMA verdicts. The value of 40.80 represents the current metric, highlighting the potential of the patent-protected consumables market for the lifelong therapy of children with peanut allergies.

dbv-technologies.com (DBVT) - Year-over-year earnings per share growth for the last 12 months from 07/04/2022 to 11/12/2026

Financial and market metric breakdowns for DBV Technologies S.A. (DBVT)

- share price and expert price forecast:
Stock Price dbv-technologies.com|DBVT - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value DBV Technologies SA|DBVT - Business Value
- book capitalization data:
Book Value per Share DBV Technologies|DBVT - Accounting Capitalization|Market Capitalization to Book Value Ratio dbv-technologies.com|DBVT - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio DBV Technologies S.A.|DBVT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio dbv-technologies.com|DBVT - Aggregate Debt Obligations|Debt to Book Value DBV Technologies SA|DBVT - Amount of Long-Term Liabilities|Company Short-Term Debts DBV Technologies|Quick Ratio dbv-technologies.com
- earnings and valuation multiples indicators:
DBVT - Net Income|Projected Future Earnings DBV Technologies S.A.|DBVT - Company Value to Net Income|Future Price to Earnings dbv-technologies.com|DBVT - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DBV Technologies SA|DBVT - Profit before interest, taxes and amortization|Earnings per share for the last twelve months DBV Technologies|DBVT - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months dbv-technologies.com|DBVT - Earnings per share growth rate in current year|Earnings growth forecast for next year DBV Technologies S.A.
Summary company analytics:DBV Tech, DBVT
Finished products of DBV Technologies

This indicator determines the investment reliability of the issuer through the dynamics of net profit per share. The metric calculates the percentage deviation of the current quarterly EPS from the value of the same period last year. By analyzing the level of quarterly EPS change, the investor assesses the real growth rate of capitalization. Positive momentum confirms the effectiveness of the unique immunotherapy provided by DBV Technologies S.A. (DBVT). Patent protection of the method minimizes the risk of generics, ensuring the stability of business margins.

Competitor analysis for DBV Technologies S.A.

KRYS: Quarterly EPS earnings growth|APGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Arcutis Biotherapeutics Inc|Year-over-year earnings per share growth for the last 12 months VCEL (Vericel Inc.)|Quarterly EPS earnings growth ORKA|sanaramedtech.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth SLSN (Solesence)|Journey Medical Corp - Year-over-year earnings per share growth for the last twelve months|FBRX: Year-over-year net earnings per share growth for the last 12 months|EMPG: Year-over-year earnings per share growth for the last twelve months|SLGL (Sol-Gel Technologies) - Year-over-year net earnings per share growth for the last 12 months|AXIL Brands - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months MDCX|VRCA (Verrica) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth HOTH|BFRI - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth VYNE (VYNE Therapeutics Inc.)|SNOA - Year-over-year net earnings per share growth for the last 12 months|Quoin Pharma - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months AZTR (Azitra Inc)|Dermata (DRMA) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ELAB|Year-over-year earnings per share growth for the last twelve months Revance Therapeutics